Member Info for riskypete

Last year proved a bit of a disappointment for chaco due to lack of rigs. With the rigs becoming available we will be one of the top performing aim shares of 2007.

obviously KevJ never ment this xmas, probably not next xmas either. I dont want to be overoptimisic but I can see these reaching 1p before 2010, all going well.

Glaxo can keep there greedy mits of our company, as far as Im concerened. At least till its sp has passed the £.

When to sell, always the big question. If I could get above 12p before the news, I would sell some. Otherwise I will keep the lot. I,ll probably sell a few after the news and hope we get the license deal before april so I can sell to use this years tax allowence. Ill still be keeping around 25% for a few years. Bad news and these triky decisions wont have to be made.

Assuming good mg6 results. Europe license agreament in first 5 months. American partner 4 to 8 months. Both these will add significant value. Results for stage 2 5161 2nd half of year. Plus some anouncement on 7056X.

Now that the trial has finished and we have the necasery funding raised, It looks good for January. Raising the funding on the back of a positive result may have anchored the sp. With that out the way, we are ready to fly.

Looks like we have reached the bottom of the dip, might start to climb next week

I must have got mubbled up with another share. SORRY

Indead it looking good for rises fopr a few weeks at least. Dips expected but not appreciated.

I have just checked it was not there I read it. I will look tommorow annd see if I can find it for you. I will let you know how I get on.

go to iii, then aim market. It gives you all aim rns releases. big deal possibly coming your way.

Todays Rise is disapearing, Drat and triple Drat.

I wish I was in there with you. Almost tempted to get in now as if the deal goes through, what you have sean so far will be small pottatoes. I am cash straped, so i will just let you get rich

chaco are just about to turn the corner. The first wells are farly shallow and hence have less risk. If you nead the cash ofcourse you would have to sell. Otherwise hold, you wont find a better oil minnow than this.

The first news we get in December should be the trial is finished. The analysis of the results will take about a fortnight to complete. I anticipate a lot of speculative activity after the trial is finished. What we have seen so far is small potatoes.

Management buy out happening definitely.

You could all follow this one up past 35p at least. Easy money

That is what they say. Certainly cenes are undervalued, but when we get the license deal after mg6 trials are finished 30p would seam a little low.

Cenes is at a low price due to needing funding, trials not finished and market lack of interest. They estimate cuurent value should be sp=30p. They point out mg6 must be effectively acting as a pain killer as if it did not it would leak out of the trial. So it is only the amount it stops sickness and other side effects of morphine that are on trial. They reckon it is almost inconcevable the trial will not be a success. Reading betwean the lines, there may not be a major increase in sp till they sign a license deal. check it yourself by doing a google search for objective capital

objective capital does research reports for cenes, check it out